No Love Lost? As Acquisition Nears, Hyseq Ponders Future of Variagenics Technology | GenomeWeb

Two months after announcing its intent to acquire Variagenics for its cash, Hyseq said it is close to deciding which technologies it will keep and which it will abandon. At this point, Variagenics’ SNP database appears to have the edge and will likely have a home when the two companies tie the knot at the end of this month.

In December, results of a review committee prompted Hyseq to lay off 65 employees at its Sunnyvale, Calif., headquarters; some of the 80 staffers who work at the company’s Boston space are now under review and may face a similar fate.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.